FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2086645669> ?p ?o ?g. }

• W2086645669 endingPage "308" @default.
• W2086645669 startingPage "299" @default.
• W2086645669 abstract "Mesalazine (5-aminosalicylic acid, 5-ASA), an anti-inflammatory agent for the treatment of inflammatory bowel diseases, is metabolized in organism to the principal biotransformation product, N-acetyl-5-ASA. Some other phase II metabolites (N-formyl-5-ASA, N-butyryl-5-ASA, N-β-d-glucopyranosyl-5-ASA) have also been described. 5-ASA is a polar compound and besides it exhibits amphoteric properties. The extraction of this compound from biomatrices and its chromatographic analysis is complicated. In order to improve the reliability of the determination of parent 5-ASA, a derivatization of 5-ASA together with 4-ASA (added to samples as a precursor of I.S.-2) was involved into the method. More lipophilic N-propionyl-5-ASA and N-propionyl-4-ASA (I.S.-2) were obtained using propionic anhydride. These derivatives were well extractable together with N-acyl-5-ASAs (metabolites) and N-acetyl-4-ASA (I.S.-1). As the first internal standard (I.S.-1) was used for the evaluation of extracted N-acyl-metabolites, the second internal standard (I.S.-2) served for the evaluation of both derivatization and extraction steps of parent drug 5-ASA. Based on these reasonings, new HPLC bioanalytical method for the determination of 5-ASA and its metabolites in blood plasma was developed and validated. The sample preparation step consists of the deproteination of plasma by HClO4 and the above-mentioned derivatization of ASAs followed by liquid–liquid extraction of all N-acyl-ASA-derivatives. Chromatographic analyses were performed on a 250-4 mm column containing Purospher RP-18 e, 5 μm (Merck, Darmstadt, Germany) with a precolumn (4-4 mm). The column effluent was monitored using both UV photodiode-array (λ = 313 nm) and fluorescence detectors (λexc. = 300 nm/λemiss. = 406 nm) in tandem. The identity of individual N-acyl-ASAs in the extracts from biomatrices was verified by characteristic UV-spectra and by HPLC/MS experiments. The whole analysis lasted 23 min at the flow rate of 1 ml min−1. LLOQ (LOD) was estimated 126 (20) pmol ml−1 of plasma for N-acetyl-5-ASA and 318 (50) pmol ml−1 of plasma for N-propionyl-5-ASA. The validated HPLC method was applied to pharmacokinetic studies of mesalazine in humans and animals." @default.
• W2086645669 created "2016-06-24" @default.
• W2086645669 creator A5001951129 @default.
• W2086645669 creator A5004532459 @default.
• W2086645669 creator A5023320230 @default.
• W2086645669 creator A5051248160 @default.
• W2086645669 creator A5052476118 @default.
• W2086645669 creator A5057012496 @default.
• W2086645669 date "2006-06-01" @default.
• W2086645669 modified "2023-10-18" @default.
• W2086645669 title "High-performance liquid-chromatographic determination of 5-aminosalicylic acid and its metabolites in blood plasma" @default.
• W2086645669 cites W1565428472 @default.
• W2086645669 cites W1602033104 @default.
• W2086645669 cites W1770909803 @default.
• W2086645669 cites W1795574849 @default.
• W2086645669 cites W1963909623 @default.
• W2086645669 cites W1964446881 @default.
• W2086645669 cites W1968178983 @default.
• W2086645669 cites W1972161651 @default.
• W2086645669 cites W1977749675 @default.
• W2086645669 cites W1979425960 @default.
• W2086645669 cites W1993529640 @default.
• W2086645669 cites W1996363518 @default.
• W2086645669 cites W2002532364 @default.
• W2086645669 cites W2004285246 @default.
• W2086645669 cites W2007598451 @default.
• W2086645669 cites W2007955344 @default.
• W2086645669 cites W2013620154 @default.
• W2086645669 cites W2016562843 @default.
• W2086645669 cites W2017167069 @default.
• W2086645669 cites W2027828317 @default.
• W2086645669 cites W2034433639 @default.
• W2086645669 cites W2034441353 @default.
• W2086645669 cites W2038519745 @default.
• W2086645669 cites W2038535256 @default.
• W2086645669 cites W2046808018 @default.
• W2086645669 cites W2047377850 @default.
• W2086645669 cites W2053331429 @default.
• W2086645669 cites W2063806411 @default.
• W2086645669 cites W2072029446 @default.
• W2086645669 cites W2079889132 @default.
• W2086645669 cites W2081560138 @default.
• W2086645669 cites W2085295394 @default.
• W2086645669 cites W2085825109 @default.
• W2086645669 cites W2169085598 @default.
• W2086645669 cites W2327240012 @default.
• W2086645669 cites W61733039 @default.
• W2086645669 doi "https://doi.org/10.1016/j.chroma.2006.01.058" @default.
• W2086645669 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16466733" @default.
• W2086645669 hasPublicationYear "2006" @default.
• W2086645669 type Work @default.
• W2086645669 sameAs 2086645669 @default.
• W2086645669 citedByCount "74" @default.
• W2086645669 countsByYear W20866456692012 @default.
• W2086645669 countsByYear W20866456692013 @default.
• W2086645669 countsByYear W20866456692014 @default.
• W2086645669 countsByYear W20866456692015 @default.
• W2086645669 countsByYear W20866456692016 @default.
• W2086645669 countsByYear W20866456692017 @default.
• W2086645669 countsByYear W20866456692019 @default.
• W2086645669 countsByYear W20866456692020 @default.
• W2086645669 countsByYear W20866456692021 @default.
• W2086645669 countsByYear W20866456692022 @default.
• W2086645669 countsByYear W20866456692023 @default.
• W2086645669 crossrefType "journal-article" @default.
• W2086645669 hasAuthorship W2086645669A5001951129 @default.
• W2086645669 hasAuthorship W2086645669A5004532459 @default.
• W2086645669 hasAuthorship W2086645669A5023320230 @default.
• W2086645669 hasAuthorship W2086645669A5051248160 @default.
• W2086645669 hasAuthorship W2086645669A5052476118 @default.
• W2086645669 hasAuthorship W2086645669A5057012496 @default.
• W2086645669 hasConcept C137535248 @default.
• W2086645669 hasConcept C178790620 @default.
• W2086645669 hasConcept C179998833 @default.
• W2086645669 hasConcept C181199279 @default.
• W2086645669 hasConcept C185592680 @default.
• W2086645669 hasConcept C2776923573 @default.
• W2086645669 hasConcept C2777477808 @default.
• W2086645669 hasConcept C2778576202 @default.
• W2086645669 hasConcept C27881333 @default.
• W2086645669 hasConcept C43617362 @default.
• W2086645669 hasConcept C4725764 @default.
• W2086645669 hasConcept C55493867 @default.
• W2086645669 hasConceptScore W2086645669C137535248 @default.
• W2086645669 hasConceptScore W2086645669C178790620 @default.
• W2086645669 hasConceptScore W2086645669C179998833 @default.
• W2086645669 hasConceptScore W2086645669C181199279 @default.
• W2086645669 hasConceptScore W2086645669C185592680 @default.
• W2086645669 hasConceptScore W2086645669C2776923573 @default.
• W2086645669 hasConceptScore W2086645669C2777477808 @default.
• W2086645669 hasConceptScore W2086645669C2778576202 @default.
• W2086645669 hasConceptScore W2086645669C27881333 @default.
• W2086645669 hasConceptScore W2086645669C43617362 @default.
• W2086645669 hasConceptScore W2086645669C4725764 @default.
• W2086645669 hasConceptScore W2086645669C55493867 @default.
• W2086645669 hasFunder F4320321005 @default.
• W2086645669 hasIssue "1-2" @default.
• W2086645669 hasLocation W20866456691 @default.

• next